Balversa 3 mg
Balversa 3 mg is a medicine authorised by Swissmedic under authorisation number 67660. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 14 January 2025 and the authorisation is limited until 13 January 2030. ATC code L01EN01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67660 |
|---|---|
| Name | Balversa 3 mg |
| Full name | Balversa 3 mg, Filmtabletten |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EN01 |
| First authorisation | 14 January 2025 |
| Authorisation validity | 13 January 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Balversa 3 mg, Filmtabletten | A | 14 January 2025 |
| 2 | Balversa 4 mg, Filmtabletten | A | 14 January 2025 |
| 3 | Balversa 5 mg, Filmtabletten | A | 14 January 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 56 | Tablette(n) | L01EN01 | 07.16.1. | A |
| 2 | 84 | Tablette(n) | L01EN01 | 07.16.1. | A |
| 3 | 28 | Tablette(n) | L01EN01 | 07.16.1. | A |
| 4 | 56 | Tablette(n) | L01EN01 | 07.16.1. | A |
| 5 | 28 | Tablette(n) | L01EN01 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Balversa 3 mg authorised in Switzerland?
Yes. Balversa 3 mg is authorised by Swissmedic under authorisation number 67660, data as of 01 September 2026. The authorisation is limited until 13 January 2030.
Which dispensing category does Balversa 3 mg have?
Balversa 3 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Balversa 3 mg?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.